Back to search
FDAFDA · Food and drugs·Recall number D-0437-2017

Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31.

Published February 1, 2017 · Recall initiated: December 22, 2016

Summary

FDA records drug Class II recall D-0437-2017, published February 1, 2017 and initiated December 22, 2016. Recalling firm: Roxane Laboratories, Inc.; Status: Terminated; Reported quantity: 6493 bottles; Lot: Lot# 660833A, Exp 08/31/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

What to do

Voluntary: Firm initiated · Letter

Get an email if FUROSEMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FUROSEMIDE
Manufacturer
Roxane Laboratories, Inc.
Distributor
Nationwide in the USA
UPC
0300544301251
Lot
Lot# 660833A, Exp 08/31/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31. recalled?

Yes. FDA published recall D-0437-2017 on February 1, 2017. Reported hazard: Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FUROSEMIDE. UPC: 0300544301251.